Likewise, I'm going to save my breath until the presentation is concluded. Isn't it nice that we have an opportunity to digest any new data, insights and potential trial design(s) over the weekend? Going into the webcast, I simply believe it is best to keep in mind the priority is improvement and extension of life. How that is to be ferreted out in a reasonable time frame through upcoming independent phase II trials will, no doubt, become more clear in a few hours.
News 
Market Data 
Discover 
